BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 30182804)

  • 1. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.
    Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN
    J Womens Health (Larchmt); 2019 Feb; 28(2):117-134. PubMed ID: 30182804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
    Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN;
    Menopause; 2018 Oct; 25(10):1069-1085. PubMed ID: 30179986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.
    Stute P; Spyropoulou A; Karageorgiou V; Cano A; Bitzer J; Ceausu I; Chedraui P; Durmusoglu F; Erkkola R; Goulis DG; Lindén Hirschberg A; Kiesel L; Lopes P; Pines A; Rees M; van Trotsenburg M; Zervas I; Lambrinoudaki I
    Maturitas; 2020 Jan; 131():91-101. PubMed ID: 31740049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and the menopause: why antidepressants are not enough?
    Graziottin A; Serafini A
    Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.
    Toffol E; Heikinheimo O; Partonen T
    Menopause; 2015 May; 22(5):564-78. PubMed ID: 25203891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
    Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
    J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood disorders in midlife women: understanding the critical window and its clinical implications.
    Soares CN
    Menopause; 2014 Feb; 21(2):198-206. PubMed ID: 24448106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms assessed in studies on perimenopausal depression: A narrative review.
    Willi J; Ehlert U
    Sex Reprod Healthc; 2020 Dec; 26():100559. PubMed ID: 33010665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of mood disorders during the menopausal transition.
    Cohen LS; Soares CN; Joffe H
    Am J Med; 2005 Dec; 118 Suppl 12B():93-7. PubMed ID: 16414333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of perimenopausal depression: A review.
    Willi J; Ehlert U
    J Affect Disord; 2019 Apr; 249():216-222. PubMed ID: 30776662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapeutic approaches to treating depression during the perimenopause.
    Garay RP; Charpeaud T; Logan S; Hannaert P; Garay RG; Llorca PM; Shorey S
    Expert Opin Pharmacother; 2019 Oct; 20(15):1837-1845. PubMed ID: 31355688
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition.
    Joffe H; Petrillo LF; Koukopoulos A; Viguera AC; Hirschberg A; Nonacs R; Somley B; Pasciullo E; White DP; Hall JE; Cohen LS
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1044-54. PubMed ID: 21525161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression during the menopause transition: impact on quality of life, social adjustment, and disability.
    Wariso BA; Guerrieri GM; Thompson K; Koziol DE; Haq N; Martinez PE; Rubinow DR; Schmidt PJ
    Arch Womens Ment Health; 2017 Apr; 20(2):273-282. PubMed ID: 28000061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
    Yisma E; Eshetu N; Ly S; Dessalegn B
    BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical challenges of perimenopause: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(1):5-13. PubMed ID: 10646698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perimenopause: From Research to Practice.
    Santoro N
    J Womens Health (Larchmt); 2016 Apr; 25(4):332-9. PubMed ID: 26653408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of perimenopausal and menopausal symptoms.
    Duralde ER; Sobel TH; Manson JE
    BMJ; 2023 Aug; 382():e072612. PubMed ID: 37553173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perimenopause and incidence of depression in midlife women: a population-based study in Taiwan.
    Lin HL; Hsiao MC; Liu YT; Chang CM
    Climacteric; 2013 Jun; 16(3):381-6. PubMed ID: 22963154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.